LVW Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.67M Buy
3,911
+173
+5% +$70.9K 0.14% 88
2026
Q2
$1.46M Sell
3,738
-55
-1% -$23.3K 0.13% 101
2026
Q1
$1.8M Buy
3,793
+201
+6% +$101K 0.17% 67
2025
Q4
$1.68M Hold
3,592
– – 0.17% 73
2025
Q3
$1.53M Sell
3,592
-47
-1% -$18.2K 0.16% 80
2025
Q2
$1.39M Buy
3,639
+653
+22% +$235K 0.15% 85
2025
Q1
$1.03M Buy
2,986
+94
+3% +$30.2K 0.12% 106
2024
Q4
$868K Sell
2,892
-1,492
-34% -$521K 0.1% 126
2024
Q3
$1.78M Buy
4,384
+69
+2% +$25.3K 0.23% 69
2024
Q2
$1.39M Buy
4,315
+1,126
+35% +$366K 0.2% 76
2024
Q1
$1.06M Buy
3,189
+1,381
+76% +$422K 0.18% 86
2023
Q4
$489K Buy
+1,808
New +$447K 0.09% 159

Other funds holding HCA

LVW Advisors's HCA Position: Q3 2026 in Review

LVW Advisors increased its HCA Healthcare (HCA) stake by 4.6% in Q3 2026, buying an estimated $70.9K and bringing the position to 3,911 shares worth $1.67M. The position accounts for 0.14% of the portfolio, ranked #88.

LVW Advisors first reported a position in HCA in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.8M in Q1 2026. 1,359 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • LVW Advisors held 3,911 shares of HCA Healthcare worth $1.67M as of Q3 2026.
  • LVW Advisors bought 173 HCA Healthcare shares in Q3 2026, an estimated $70.9K.
  • HCA Healthcare made up 0.14% of LVW Advisors's portfolio in Q3 2026, its #88 holding.
  • LVW Advisors first reported a position in HCA Healthcare in Q4 2023 and has held it in 12 quarters since.
  • LVW Advisors's HCA Healthcare position peaked at $1.8M in Q1 2026.
  • 1,359 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on LVW Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.